fluorometholone has been researched along with Disease Models, Animal in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Calpena, AC; Egea, MA; Espina, M; García, ML; Gonzalez-Pizarro, R; Silva-Abreu, M | 1 |
| Chae, JJ; Chuck, RS; Hongyok, T; Li, L; Na, D; Shin, YJ | 1 |
| Chiu, TY; Choy, KW; Fan, DS; Lam, DS; Lam, S; Li, WY; Liu, DT; Pang, CP; Qin, Y; Yam, GH | 1 |
| Bock, F; Cursiefen, C; Hos, D; Masli, S; Onderka, J; Regenfuss, B; Saban, DR | 1 |
| Chang, CK; Du, Z; Huang, Z; Liu, W; Liu, X; Zhao, W | 1 |
| Chuck, RS; Zhang, C; Zhu, L | 1 |
| Choi, SB; Kim, JS; Kwon, JW; Lee, JH; Wee, WR | 1 |
| Chuck, RS; Lekhanont, K; Leyngold, IM; Rangsin, R; Suwan-Apichon, O | 1 |
| Berrospi, AR; Kupferman, A; Leibowitz, HM | 1 |
| Baru, H; Howes, JF; Neumann, R; Vered, M | 1 |
| Bhattacherjee, P; Graff, G; Paterson, CA; Spellman, JM; Yanni, JM | 1 |
12 other study(ies) available for fluorometholone and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Development of fluorometholone-loaded PLGA nanoparticles for treatment of inflammatory disorders of anterior and posterior segments of the eye.
Topics: Administration, Ophthalmic; Animals; Anti-Inflammatory Agents; Biological Availability; Chickens; Chorioallantoic Membrane; Cornea; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Eye Diseases; Fluorometholone; Inflammation; Lactic Acid; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sclera; Swine | 2018 |
Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye.
Topics: Acetylcysteine; Administration, Topical; Animals; Blinking; Botulinum Toxins; Botulinum Toxins, Type A; Chitosan; Conjunctiva; Cornea; Cytokines; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescent Antibody Technique, Indirect; Fluorometholone; Lacrimal Apparatus; Mice; Mice, Inbred CBA; Ophthalmic Solutions; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tears | 2009 |
A rabbit model of age-dependant ocular hypertensive response to topical corticosteroids.
Topics: Administration, Topical; Age Factors; Androstadienes; Animals; Dexamethasone; Disease Models, Animal; Extracellular Matrix Proteins; Fluorometholone; Glucocorticoids; Intraocular Pressure; Loteprednol Etabonate; Male; Ocular Hypertension; Ophthalmic Solutions; Pregnadienes; Rabbits; Tonometry, Ocular; Trabecular Meshwork | 2012 |
Suppression of inflammatory corneal lymphangiogenesis by application of topical corticosteroids.
Topics: Administration, Topical; Animals; Cell Culture Techniques; Cell Proliferation; Corneal Neovascularization; Dexamethasone; Disease Models, Animal; Endothelium, Lymphatic; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Fluorometholone; Glucocorticoids; Hyaluronan Receptors; Lymphangiogenesis; Lymphatic Vessels; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Prednisolone | 2011 |
Inhibition effect of tetrandrine on haze formation after Epi-LASIK surgery in rabbits.
Topics: Animals; Benzylisoquinolines; Collagen Type III; Corneal Opacity; Corneal Stroma; Disease Models, Animal; Drugs, Chinese Herbal; Female; Fluorometholone; Immunoenzyme Techniques; Immunosuppressive Agents; Keratomileusis, Laser In Situ; Male; Ophthalmic Solutions; Postoperative Complications; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta2 | 2011 |
Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Botulinum Toxins; Botulinum Toxins, Type A; Conjunctiva; Cornea; Disease Models, Animal; Dry Eye Syndromes; Female; Fluorescein; Fluorometholone; Glucocorticoids; Interleukin-1beta; Ketorolac; Lacrimal Apparatus; Mice; Mice, Inbred CBA; Ophthalmic Solutions; Phenylacetates; Tears; Tumor Necrosis Factor-alpha | 2012 |
Experimental study of an automated system for the delivery of eyedrops using a microinfusion pump.
Topics: Animals; Burns, Chemical; Cornea; Corneal Injuries; Disease Models, Animal; Drug Delivery Systems; Eye Burns; Feasibility Studies; Fluorometholone; Glucocorticoids; Infusion Pumps; Ophthalmic Solutions; Rabbits; Sodium Hydroxide; Tears | 2005 |
Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model.
Topics: Administration, Topical; Animals; Blinking; Botulinum Toxins; Botulinum Toxins, Type A; Cornea; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Female; Fluorescent Dyes; Fluorometholone; Keratoconjunctivitis Sicca; Mice; Mice, Inbred CBA; Ophthalmic Solutions; Sodium Chloride; Staining and Labeling; Tears | 2007 |
Fluorometholone acetate. A new ophthalmic derivative of fluorometholone.
Topics: Acetates; Animals; Anti-Inflammatory Agents; Disease Models, Animal; Drug Administration Schedule; Female; Fluorometholone; Keratitis; Leukocytes; Male; Prednisolone; Rabbits | 1982 |
Loteprednol etabonate: comparison with other steroids in two models of intraocular inflammation.
Topics: Androstadienes; Animals; Anti-Inflammatory Agents; Chronic Disease; Dexamethasone; Disease Models, Animal; Fluorometholone; Intraocular Pressure; Loteprednol Etabonate; Ophthalmic Solutions; Rabbits; Uveitis, Anterior | 1994 |
Pharmacological validation of a feline model of steroid-induced ocular hypertension.
Topics: Administration, Topical; Androstadienes; Animals; Cats; Dexamethasone; Disease Models, Animal; Female; Fluorometholone; Glucocorticoids; Humans; Intraocular Pressure; Loteprednol Etabonate; Ocular Hypertension; Ophthalmic Solutions; Prednisolone; Pregnadienes; Random Allocation; Reproducibility of Results; Tonometry, Ocular | 1999 |